BCAL Diagnostics LimitedASX: BDX

Appendix 4G and Corporate Governance Statement

· Issued by BCAL Diagnostics Limited via ASX

Filed with ASX ·

Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity BCAL Diagnostics Limited ABN/ARBN Financial year ended: 51 142 051 223 30 June 2026 ...

View Attachment

6ix hasn’t read this filing yet.

BCAL Diagnostics Limited on 6ix

Earlier from BCAL Diagnostics

Later from BCAL Diagnostics

All BCAL Diagnostics news releases